1 Result: Alcon
Key Partnerships and Promising Initiations: Lifecore Biomedical and Alcon Forge New Agreements, while Avanos, CONMED, and Recursion Pharma Garner Positive Ratings
May 22nd, 2023
Lifecore Biomedical, Inc. (Nasdaq: LFCR) and Alcon Inc. (NYSE: ALC) have entered into a wide-ranging set of agreements, including a new $150 million credit arrangement. This credit facility will enable Lifecore to repay its existing credit agreement . Read more
Load More Content
Member Login